Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;113(1):96-104.
doi: 10.2105/AJPH.2022.307112.

SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022

Affiliations

SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022

Wanzhu Tu et al. Am J Public Health. 2023 Jan.

Erratum in

Abstract

Objectives. To assess the effectiveness of vaccine-induced immunity against new infections, all-cause emergency department (ED) and hospital visits, and mortality in Indiana. Methods. Combining statewide testing and immunization data with patient medical records, we matched individuals who received at least 1 dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines with individuals with previous SARS-CoV-2 infection on index date, age, gender, race/ethnicity, zip code, and clinical diagnoses. We compared the cumulative incidence of infection, all-cause ED visits, hospitalizations, and mortality. Results. We matched 267 847 pairs of individuals. Six months after the index date, the incidence of SARS-CoV-2 infection was significantly higher in vaccine recipients (6.7%) than the previously infected (2.9%). All-cause mortality in the vaccinated, however, was 37% lower than that of the previously infected. The rates of all-cause ED visits and hospitalizations were 24% and 37% lower in the vaccinated than in the previously infected. Conclusions. The significantly lower rates of all-cause ED visits, hospitalizations, and mortality in the vaccinated highlight the real-world benefits of vaccination. The data raise questions about the wisdom of reliance on natural immunity when safe and effective vaccines are available. (Am J Public Health. 2023;113(1):96-104. https://doi.org/10.2105/AJPH.2022.307112).

PubMed Disclaimer

Figures

FIGURE 1—
FIGURE 1—
Construction of Matched Cohorts of Infected and Vaccinated Individuals: SARS-COV-2 Infection, Hospitalizations, and Mortality in Vaccinated and Infected Individuals, Indiana, 2020‒2022 Note. DOB = date of birth; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.
FIGURE 2—
FIGURE 2—
Cumulative Incidence Rates, in Vaccine Recipients and Individuals With Previous Infections, of (a) SARS-CoV-2 Infection or Reinfection, (b) Emergency Department Visit, (c) All-Cause Hospitalization, and (d) Death: SARS-COV-2 Infection, Hospitalizations, and Mortality in Vaccinated and Infected Individuals, Indiana, 2020‒2022 Note. SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.

Similar articles

Cited by

References

    1. Bajema KL, Dahl RM, Prill MM, et al. Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization—five Veterans Affairs medical centers, United States, February 1‒ August 6, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1294–1299. doi: 10.15585/mmwr.mm7037e3. - DOI - PMC - PubMed
    1. Livingston EH, Malani PN, Creech CB. The Johnson & Johnson Vaccine for COVID-19. JAMA. 2021;325(15):1575. doi: 10.1001/jama.2021.2927. - DOI - PubMed
    1. Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412–1423. doi: 10.1056/NEJMoa2101765. - DOI - PMC - PubMed
    1. Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care wettings. N Engl J Med. 2021;385(15):1355–1371. doi: 10.1056/NEJMoa2110362. - DOI - PMC - PubMed
    1. Grannis SJ, Rowley EA, Ong TC, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance—nine states, June‒August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1291–1293. doi: 10.15585/mmwr.mm7037e2. - DOI - PMC - PubMed